Relay Therapeutics raises $400 mln

Relay Therapeutics said Dec. 20 that it raised $400 million in Series C financing led by the SoftBank Vision Fund. New investors included Foresite Capital, Perceptive Advisors and Tavistock Group. Existing investors GV, Casdin Capital, BVF Partners, EcoR1 Capital, Alexandria Venture Investments, and an affiliate of D.E. Shaw Research also participated. Relay Therapeutics, of Cambridge, Massachusetts, is a biotech.

North AmericaUSHealthcareBriefs